Guangzhou Xuefeng Information Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Xuefeng Information Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include COMDECEVIS. The owner is based in Guangzhou, Guangdong.

Room 601, No. 17, Zexi Street

Hanxi Village(Hanxi Commercial Center), Zhongcun Subdistrict, Panyu District

Guangzhou, Guangdong 511400 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Guangzhou Xuefeng Information Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Guangzhou Xuefeng Information Technology Co., Ltd. have?

Guangzhou Xuefeng Information Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Guangzhou Xuefeng Information Technology Co., Ltd. file in?

Guangzhou Xuefeng Information Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Guangzhou Xuefeng Information Technology Co., Ltd.'s most well-known trademarks?

Guangzhou Xuefeng Information Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as COMDECEVIS. These are among 2 currently registered trademarks in the portfolio.

What is Guangzhou Xuefeng Information Technology Co., Ltd.'s trademark registration success rate?

Guangzhou Xuefeng Information Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.